This week, we hosted our annual FBRI workshop on Alzheimer’s Disease and Related Disorders in Kronberg, Germany. The event featured academic and industry experts from around the world who gathered to connect and discuss and the latest advancements in science and medicine. Stacie Weninger, Ph.D., President of FBRI and Venture Partner at F-Prime Capital, alongside Matthew Boersma, Ph.D., Associate Director at FBRI, led the event, where leading scientists shared valuable insights into novel disease biology and therapeutic strategies for neurodegeneration. It was invigorating to continue these in-person discussions and strengthen connections within the life sciences industry. #Alzheimers #Neuroscience #AlzheimersandBrainAwarenessMonth #EndALZ Stephen Knight, M.D. │ Robert Weisskoff. Ph.D. │ Alex Pasteur, Ph.D. │ Davina Magargal
F-Prime Capital’s Post
More Relevant Posts
-
🧬 Delving into the realm of Parkinson's disease research, an innovative protocol to investigate Allele-specific Expression (ASE) in human brain samples. https://lnkd.in/dthkcdG8 by Maria Diaz Ortiz, PhD, Nimansha J., Michael Gallagher,Marijan Posavi,Travis Unger and Alice S. Chen-Plotkin at University of Pennsylvania, University of Pennsylvania School of Medicine, Washington University School of Medicine in St. Louis,Whitehead Institute. ➡ Analyzed the GPNMB and KLHL7 genes associated with Parkinson's disease risk, deepening our understanding of this complex disorder. ➡Method offers heightened sensitivity, providing a blueprint for studying a range of genes and disease states. 🧠✨ #ParkinsonsResearch #GeneExpression #Neuroscience #Innovation #brain #bioprotocol #reproducibility #reproduciblescience #openaccess
To view or add a comment, sign in
-
Passionate about partnering with researchers/clinicians for impactful publications. Dedicated Patient Advocate for Cervical Cancer & HPV Awareness. Let's connect! #Research #HealthAdvocacy
📢 Excited to announce the release of "Mechanisms of Disease Pathogenesis in Multiple Sclerosis," edited by Francisco Javier Quintana! This comprehensive book delves into MS, its clinical features, available biomarkers, and the mechanisms driving disease pathogenesis. It also covers the influence of genetic and environmental factors and highlights novel therapies for disease management. A must-read for neurologists, neuroimmunologists, and researchers dedicated to understanding neurodegeneration. Get your copy today: https://bit.ly/4b5WNGK #MultipleSclerosis #Neurodegeneration #NewBook #Neuroscience #ElsevierBooks
To view or add a comment, sign in
-
In Australia, and around the world, the challenges of aging are becoming more relevant every day and there are teams of amazing researchers trying to understand the science of aging and how to manage this natural stage of life. If this is an areas of your research and you wanted to learn how SomaScan 7000 plex assay could be combined with mass spec, and other omics data, then take some time to listen to the webinar linked below #aging #precisionmedicine #proteomics #neurodegenerativedisease
Combining protein profiling with mass spec and other omics data is giving researchers deeper insights into human aging and age-related diseases. Four experts explain their approach in our recent seminar: https://bit.ly/3Piyspw Our speakers: - Eric Morgen, MD, MPH, FRCPC, BioAge Labs - Paola Sebastiani, PhD, Tufts Medical Center - Birgit Schilling, PhD, Buck Institute for Research on Aging - Alessandro Ori, PhD, Genentech Headed to #HUPO2023 soon? Stop by Booth 405 to learn more about a complementary approach. See our full schedule here: https://bit.ly/44E4Hnt #biomarkers #neuroscience #drugdiscovery #proteomics
To view or add a comment, sign in
-
Discover the groundbreaking research at Pratico Lab! 🧪🔬 Led by Dr. Domenico Pratico, the lab is on a mission to bring about the first life-changing Alzheimer’s treatment. Their focus? Oxidized lipids - small molecules that could be the hidden culprits behind aging and disease. Join us in exploring the cellular and molecular aspects of cell oxidative biology and their significance as potential therapeutic targets for neurodegenerative diseases. Together, we can envision a world free from Alzheimer’s fear, harm, and heartbreak, with memories to last a lifetime. Stay tuned for more updates from Pratico Lab! 🌐 www.drdomenicopratico.com | www.thepraticolab.com 📚 https://lnkd.in/ePYMYRWn 🧠 https://lnkd.in/eJjn_Shz 🐦 https://lnkd.in/e-NvsgBK 🖋️ https://lnkd.in/ecVzXE8D #PraticoLab #AlzheimersResearch #NeuroscienceBreakthroughs #OxidizedLipids #LifeChangingTreatment #DomenicoPratico #CellOxidativeBiology #NeurodegenerativeDiseases #ResearchInnovation #MemorySolutions #ScientificDiscovery #FutureofHealthcare #AlzheimersAwareness #BreakingBarriers #HopeForTheFuture #BrainHealth #Neuroscience #PraticoLab #AlzheimersTreatment #domenicopratico #praticodomenico
To view or add a comment, sign in
-
Discover the groundbreaking research at Pratico Lab! 🧪🔬 Led by Dr. Domenico Pratico, the lab is on a mission to bring about the first life-changing Alzheimer’s treatment. Their focus? Oxidized lipids - small molecules that could be the hidden culprits behind aging and disease. Join us in exploring the cellular and molecular aspects of cell oxidative biology and their significance as potential therapeutic targets for neurodegenerative diseases. Together, we can envision a world free from Alzheimer’s fear, harm, and heartbreak, with memories to last a lifetime. Stay tuned for more updates from Pratico Lab! 🌐 www.drdomenicopratico.com | www.thepraticolab.com 📚 https://lnkd.in/ePYMYRWn 🧠 https://lnkd.in/eJjn_Shz 🐦 https://lnkd.in/e-NvsgBK 🖋️ https://lnkd.in/ecVzXE8D #PraticoLab #AlzheimersResearch #NeuroscienceBreakthroughs #OxidizedLipids #LifeChangingTreatment #DomenicoPratico #CellOxidativeBiology #NeurodegenerativeDiseases #ResearchInnovation #MemorySolutions #ScientificDiscovery #FutureofHealthcare #AlzheimersAwareness #BreakingBarriers #HopeForTheFuture #BrainHealth #Neuroscience #PraticoLab #AlzheimersTreatment #domenicopratico #praticodomenico
To view or add a comment, sign in
-
Reflecting on our team's presentation at the recent Longevity Med Summit, we're pleased to share that we received positive feedback from the audience. Understanding the importance of explaining the interplay between technology and scientific research to deliver practical digital tools to healthcare providers, we've created a video for the conference participants to share our approach to solving complex questions related to clinical biomarkers and their impact on aging assessment. Watch a sneak peek into the presentation below, as our Chief Technology Officer, Rasmus Vighagen, provides insights into our methods for decoding the aging process. #alpinelongevity #longevityresearch #decodingaging #InoHealth #Neuroscience #Preventivemedicine #AIinHealth #LongevitySummit #Innovation
To view or add a comment, sign in
-
Ncardia webinar today @10am featuring #ipscs for devt of treatments for #proteinopathies:
Last chance: register for the webinar today! Today we will dive into the use of human iPSC technology as the gateway for cutting-edge disease modeling. Our Proteinopathy Exploration Package helps assess protein aggregation in human neurons and elevates your approach to neurodegenerative diseases. Join us in catalyzing drug discovery: - Purpose-built to increase confidence - Designed to deliver robust and reproducible data - Formed to catalyze drug discovery Ready to revolutionize your research? Register now: https://lnkd.in/e3TqXfDX Live on January 29 at 4 PM CET / 10 AM ET with Jessica Koepke #drugdiscovery #neuroscience #webinar #Ncardia
To view or add a comment, sign in
-
Can we prevent Alzheimer’s? This is the question that drives the pioneering research at Pratico Lab. Led by Dr. Domenico Pratico, the lab is on a mission to bring about the first life-changing Alzheimer’s treatment. Their focus is on the cellular and molecular aspects of cell oxidative biology, with a keen interest in small molecules like bioactive oxidized lipids. These molecules could play a significant role in the pathogenesis of several neurodegenerative diseases and serve as potential therapeutic targets against them. Join us as we delve into the mysteries of Alzheimer’s, fueled by hope and guided by science. Stay tuned for more updates from Pratico Lab! 🌐 www.drdomenicopratico.com | www.thepraticolab.com 📚 https://lnkd.in/ePYMYRWn 🧠 https://lnkd.in/eJjn_Shz 🐦 https://lnkd.in/e-NvsgBK 🖋️ https://lnkd.in/ecVzXE8D #AlzheimersResearch #brainalzheimer #AlzheimersResearch #BrainHealth #Neuroscience #PraticoLab #OxidativeBiology #BioactiveLipids #NeurodegenerativeDiseases #HopeInScience #AlzheimersTreatment #domenicopratico #praticodomenico #ResearchUpdate
To view or add a comment, sign in
-
Our newest poster was presented recently at the annual meeting of the Society for Neuroscience. Alterity CEO David Stamler remarked that these data "underscore the potential of ATH434 as a treatment for neurodegenerative diseases, including Parkinson’s disease and related disorders... We are grateful for the valued contributions from our collaborators in Dr. Kosman Daniel's laboratory at SUNY-Buffalo." View the poster here: https://bit.ly/3QDmvKB #SfN23 #neuroscience2023
To view or add a comment, sign in
19,662 followers